Pacific Biosciences Of California (PACB) Change in Intangibles (2025 - 2026)
Pacific Biosciences Of California (PACB) recorded quarterly Change in Intangibles of $5.0 million in Q1 2026, little changed quarter-over-quarter from $5.0 million in Q1 2025, and little changed on a YoY basis from $5.0 million in Q1 2025.
Pacific Biosciences Of California (PACB) Change in Intangibles (2025 - 2026) Analysis & Trends
Pacific Biosciences Of California's Change in Intangibles history runs 2 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- In Q1 2026, Change in Intangibles changed 0.0% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (changed 0.0% YoY), while the FY2025 annual figure was $5.0 million, changed N/A from the prior year.
- Change in Intangibles was $5.0 million for Q1 2026 at Pacific Biosciences Of California, roughly flat from $5.0 million in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $5.0 million in Q1 2025 to a low of $5.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -31.61 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Pacific Biosciences Of California | 426.62 Mn | 150.66 Mn | 12.84 Mn | 5.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Mar 31, 2025 | 5.00 Mn |